- Investing.com
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
Metrics to compare | AIFF | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipAIFFPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −1.0x | −0.6x | |
PEG Ratio | 0.01 | −0.02 | 0.00 | |
Price/Book | 1.2x | 1.3x | 2.6x | |
Price / LTM Sales | 14.3x | 1.5x | 3.3x | |
Upside (Analyst Target) | - | 61.3% | 44.6% | |
Fair Value Upside | Unlock | 29.8% | 6.0% | Unlock |